CH373386A - Verfahren zur Herstellung von neuen 1,3-disubstituierten Phenothiazinabkömmlingen - Google Patents
Verfahren zur Herstellung von neuen 1,3-disubstituierten PhenothiazinabkömmlingenInfo
- Publication number
- CH373386A CH373386A CH6724258A CH6724258A CH373386A CH 373386 A CH373386 A CH 373386A CH 6724258 A CH6724258 A CH 6724258A CH 6724258 A CH6724258 A CH 6724258A CH 373386 A CH373386 A CH 373386A
- Authority
- CH
- Switzerland
- Prior art keywords
- disubstituted
- formula
- preparation
- phenothiazine
- new
- Prior art date
Links
- -1 1,3-disubstituted phenothiazine Chemical class 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 4
- 229940066767 systemic antihistamines phenothiazine derivative Drugs 0.000 title claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 4
- XHQVXOJAZYFHQG-UHFFFAOYSA-N 1,3-dimethyl-10h-phenothiazine Chemical compound C1=CC=C2SC3=CC(C)=CC(C)=C3NC2=C1 XHQVXOJAZYFHQG-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229950000688 phenothiazine Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000002716 ataractic effect Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS494657 | 1957-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH373386A true CH373386A (de) | 1963-11-30 |
Family
ID=5393328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6724258A CH373386A (de) | 1957-12-20 | 1958-12-12 | Verfahren zur Herstellung von neuen 1,3-disubstituierten Phenothiazinabkömmlingen |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE573769A (fr) |
| CH (1) | CH373386A (fr) |
| NL (1) | NL106300C (fr) |
-
1958
- 1958-12-10 BE BE573769A patent/BE573769A/fr unknown
- 1958-12-12 NL NL234165A patent/NL106300C/xx active
- 1958-12-12 CH CH6724258A patent/CH373386A/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE573769A (fr) | 1959-04-01 |
| NL106300C (nl) | 1963-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2508045A1 (de) | Substituierte n-(1-benzylpyrrolidinyl-2-alkyl)-benzamide, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| DE1018422B (de) | Verfahren zur Herstellung basisch substituierter Heterocyclen | |
| DE2426149B2 (de) | 7-Fluor-substituierte Phenothiazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE540697C (de) | Verfahren zur Darstellung einseitig acylierter Diamine | |
| CH373386A (de) | Verfahren zur Herstellung von neuen 1,3-disubstituierten Phenothiazinabkömmlingen | |
| DE935546C (de) | Verfahren zur Herstellung von N-Acylderivaten des Iminodibenzyls | |
| CH509311A (de) | Verfahren zur Herstellung von N-(tert.-Aminoalkyl)-amidderivaten | |
| DE2114884A1 (de) | Basisch substituierte Derivate des 1(2H)-Phthalazinons | |
| CH635834A5 (de) | Dibenzo(d,g)(1,3,6)dioxazocin-derivate, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittelpraeparate. | |
| DE1035150B (de) | Verfahren zur Herstellung von N-monosubstituierten ª‡-(tert.-Aminoalkyl)-ª‡-phenyl-acetamiden | |
| DE1136707B (de) | Verfahren zur Herstellung von N-substituierten Azepinen | |
| DE630842C (de) | Verfahren zur Darstellung von Acridinabkoemmlingen | |
| DE3328186A1 (de) | Basische acetanilide, verfahren zu deren herstellung und arzneimittel, die diese acetanilide enthalten | |
| DE881662C (de) | Verfahren zur Herstellung von Aminoalkylaethern von Diarylcarbinolen | |
| AT151653B (de) | Verfahren zur Darstellung von Perhydrocarbazolderivaten. | |
| AT256116B (de) | Verfahren zur Herstellung von neuen heterozyklischen Verbindungen | |
| AT217045B (de) | Verfahren zur Herstellung von neuen monoalkylierten bzw. monohalogenierten N-Derivaten von 10,11-Dihydro-5H-dibenzo[b,f]azepinen und 5H-Dibenzo[b,f]azepinen | |
| DE1470173C (de) | 1 geschweifte Klammer auf 3 ge schweifte Klammer auf eckige Klammer auf 5,6,7,8 Tetrahydro 4 (arylazo) 1 naphthyl eckige Klammer zu amino geschweifte Klammer zu propyl geschweifte Klammer zu piperi dinverbindungen, deren Saureadditionssalze sowie Verfahren zu ihrer Herstellung | |
| DE953798C (de) | Verfahren zur Herstellung neuer disubstituierter Nicotinsaeureamide | |
| DE1518652A1 (de) | Verfahren zur Herstellung von pharmazeutisch wirksamen Derivaten des 2-Aminoindans | |
| DE954424C (de) | Verfahren zur Herstellung von Alkylaminoalkylestern von Aminooxybenzoesaeuren | |
| DE954599C (de) | Verfahren zur Herstellung von Derivaten des 5-Amino-8-methyl-thiochromanons und -thiochromons | |
| AT311345B (de) | Verfahren zur Herstellung von neuen, heterocyclischen Aminophenylalkylaminen sowie von deren Säureadditionssalzen | |
| CH310649A (de) | Verfahren zur Herstellung eines 2-Halogen-4-amino-toluols. | |
| DEC0006830MA (fr) |